|
|
Article: Data mixed on anticholinergic use for COPD.(Pulmonary Medicine)
- Article from:
- Family Practice News
- Article date:
- December 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA -- Despite recent hints of danger, inhaled anticholinergic drugs remain a mainstay of treatment for many patients with chronic obstructive pulmonary disease.
Inhaled anticholinergic drugs such as ipratropium and tiotropium should not be used in patients with chronic obstructive pulmonary disease (COPD) who are also at high risk for cardiovascular disease complications. This high-risk group includes patients with a significant cardiac arrhythmia, a recent cardiovascular disease event, ischemic heart disease, or heart failure, Dr. R. Graham Barr said at the annual meeting of the American College of Chest Physicians. An inhaled anticholinergic drug ...